China has significantly increased the volume of domestic pharmaceutical production for the first half of the current year. During the period from January to July 2011 the value of the Chinese pharmaceutical industry amounted to 802.4 billion renminbi (about $126 billion), which is 29.6% more than in the same period of 2010.
According to the Chinese State Department for Control of Food and Drugs, the expansion continues in the second half of 2011 and there is a possibility that cumulative growth rates for 2011 may reach 35% compared to 2010.
Such growth rates are part of the strategy currently implemented by the Chinese Ministry of Health, according to which during the next several years China is expected to become one of the world’s largest pharmaceutical markets. Assuming such growth rates are maintained, by 2014 China will overtake Japan and will become the world's second largest pharmaceutical market, behind only the USA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze